FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309929523> ?p ?o ?g. }

• W4309929523 endingPage "S32" @default.
• W4309929523 startingPage "S32" @default.
• W4309929523 abstract "<h3>Study Objective</h3> To determine the effect of laparoscopic uterosacral bupivacaine injection on post-operative pain and opioid usage in patients undergoing minimally invasive hysterectomy. <h3>Design</h3> Single-Blinded, Triple-Arm, Randomized Controlled Trial. <h3>Setting</h3> Academic Hospital Center. <h3>Patients or Participants</h3> Patients undergoing benign MIGS hysterectomy between 3/15/2021 and 4/8/2022. Exclusion criteria: conversion to laparotomy, bupivacaine allergy, concurrent procedures, supracervical hysterectomy, TAP block, preoperative opioid usage, non-English speaking. <h3>Interventions</h3> Patients were randomized in a 1:1:1 fashion to the following before colpotomy: no injection, 20cc normal saline, or 20cc of 0.25% bupivacaine. All patients received incisional infiltration with 10cc 0.25% bupivacaine. Post-operative pain scores, total opioid consumption and return of bowel function were recorded via Qualtrics surveys. <h3>Measurements and Main Results</h3> Of 360 hysterectomies screened, 298 were eligible (83%), 161 (45%) agreed to participate, and 125 were ultimately included in interim analysis. The majority of hysterectomies were performed laparoscopically (91, 73%) and the remainder robotically. Most hysterectomies were discharged home POD#0 (116, 93%). Patients randomized to placebo had a lower proportion of public insurance and higher proportion of mood disorders. There was a statistical difference in the proportion of cases that required morcellation between bupivacaine and no injection (43% vs 18%, p=0.038; no difference between bupivacaine and saline, 43% and 32%, p=0.87). In regression controlling for surgical approach, administration of Toradol, and time from injection to discharge, mean pain scores on VAS at time of discharge were statistically lower in the bupivacaine group compared to placebo (-1.09, p=0.033) or no injection (-1.15, p=0.023). There was no difference between groups in PACU OME administration or post-operative OME usage, day of last use, or return of bowel function. <h3>Conclusion</h3> Laparoscopic uterosacral injection of bupivacaine at the time of MIS hysterectomy results in decreased post-operative VAS pain scores, although without a difference in post-operative opioid consumption. Complete trial data to be available at the time of AAGL." @default.
• W4309929523 created "2022-11-30" @default.
• W4309929523 creator A5007725425 @default.
• W4309929523 creator A5012906760 @default.
• W4309929523 creator A5015319790 @default.
• W4309929523 creator A5026596266 @default.
• W4309929523 creator A5030845140 @default.
• W4309929523 creator A5042701054 @default.
• W4309929523 creator A5053038334 @default.
• W4309929523 creator A5055831988 @default.
• W4309929523 creator A5068899898 @default.
• W4309929523 date "2022-11-01" @default.
• W4309929523 modified "2023-09-29" @default.
• W4309929523 title "Laparoscopic Uterosacral Bupivacaine Injection during Minimally-Invasive Hysterectomy: A Single-Blinded Randomized Controlled Trial" @default.
• W4309929523 doi "https://doi.org/10.1016/j.jmig.2022.09.106" @default.
• W4309929523 hasPublicationYear "2022" @default.
• W4309929523 type Work @default.
• W4309929523 citedByCount "0" @default.
• W4309929523 crossrefType "journal-article" @default.
• W4309929523 hasAuthorship W4309929523A5007725425 @default.
• W4309929523 hasAuthorship W4309929523A5012906760 @default.
• W4309929523 hasAuthorship W4309929523A5015319790 @default.
• W4309929523 hasAuthorship W4309929523A5026596266 @default.
• W4309929523 hasAuthorship W4309929523A5030845140 @default.
• W4309929523 hasAuthorship W4309929523A5042701054 @default.
• W4309929523 hasAuthorship W4309929523A5053038334 @default.
• W4309929523 hasAuthorship W4309929523A5055831988 @default.
• W4309929523 hasAuthorship W4309929523A5068899898 @default.
• W4309929523 hasConcept C141071460 @default.
• W4309929523 hasConcept C168563851 @default.
• W4309929523 hasConcept C2779494336 @default.
• W4309929523 hasConcept C2780047204 @default.
• W4309929523 hasConcept C2781328992 @default.
• W4309929523 hasConcept C71924100 @default.
• W4309929523 hasConceptScore W4309929523C141071460 @default.
• W4309929523 hasConceptScore W4309929523C168563851 @default.
• W4309929523 hasConceptScore W4309929523C2779494336 @default.
• W4309929523 hasConceptScore W4309929523C2780047204 @default.
• W4309929523 hasConceptScore W4309929523C2781328992 @default.
• W4309929523 hasConceptScore W4309929523C71924100 @default.
• W4309929523 hasIssue "11" @default.
• W4309929523 hasLocation W43099295231 @default.
• W4309929523 hasOpenAccess W4309929523 @default.
• W4309929523 hasPrimaryLocation W43099295231 @default.
• W4309929523 hasRelatedWork W1969974057 @default.
• W4309929523 hasRelatedWork W2047967234 @default.
• W4309929523 hasRelatedWork W2080090434 @default.
• W4309929523 hasRelatedWork W2332246336 @default.
• W4309929523 hasRelatedWork W2390961722 @default.
• W4309929523 hasRelatedWork W2439875401 @default.
• W4309929523 hasRelatedWork W4225983350 @default.
• W4309929523 hasRelatedWork W4250176978 @default.
• W4309929523 hasRelatedWork W4283770534 @default.
• W4309929523 hasRelatedWork W4295776607 @default.
• W4309929523 hasVolume "29" @default.
• W4309929523 isParatext "false" @default.
• W4309929523 isRetracted "false" @default.
• W4309929523 workType "article" @default.